NCT03934112 Impact of Transfusional Practice on the Morbidity and Mortality of Patients in Intensive Care Unit
| NCT ID | NCT03934112 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire de Besancon |
| Condition | Transfusion Related Complication |
| Study Type | OBSERVATIONAL |
| Enrollment | 150,000 participants |
| Start Date | 2020-01-03 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 150,000 participants in total. It began in 2020-01-03 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will allow correlating transfusion monitoring and patients' prognostic according to the chosen outcome criteria. These data could thus represent a basis for transfusion recommendations, except for intensive care and vital emergencies. It will also bring information about the actual transfusion monitoring in intensive care unit (ICU), in the period following the stay in the ICU and after hospital discharge.
Eligibility Criteria
Inclusion criteria: * Patient admitted to medical and surgical resuscitation units of Besançon and Dijon university hospitals, all causes considered * Patient admitted between 1st January 2012 to 31st December 2017
Contact & Investigator
Frequently Asked Questions
Who can join the NCT03934112 clinical trial?
This trial is open to participants of all sexes, studying Transfusion Related Complication. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03934112 currently recruiting?
Yes, NCT03934112 is actively recruiting participants. Contact the research team at maxime.desmarets@univ-fcomte.fr for enrollment information.
Where is the NCT03934112 trial being conducted?
This trial is being conducted at Besançon, France.
Who is sponsoring the NCT03934112 clinical trial?
NCT03934112 is sponsored by Centre Hospitalier Universitaire de Besancon. The trial plans to enroll 150,000 participants.